GABA AGONIST TREATMENT IMPROVES TARDIVE DYSKINESIA

C. A. Tamminga, G. K. Thaker, T. N. Ferraro, T. A. Hare

Research output: Contribution to journalArticle

28 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)97-98
Number of pages2
JournalThe Lancet
Volume322
Issue number8341
DOIs
StatePublished - Jul 9 1983

Fingerprint

Aminocaproates
Drug-Induced Dyskinesia
4-Aminobutyrate Transaminase
Vigabatrin
GABA Agonists
Random Allocation
Transaminases
Double-Blind Method
gamma-Aminobutyric Acid
Clinical Trials
Tardive Dyskinesia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

GABA AGONIST TREATMENT IMPROVES TARDIVE DYSKINESIA. / Tamminga, C. A.; Thaker, G. K.; Ferraro, T. N.; Hare, T. A.

In: The Lancet, Vol. 322, No. 8341, 09.07.1983, p. 97-98.

Research output: Contribution to journalArticle

Tamminga, CA, Thaker, GK, Ferraro, TN & Hare, TA 1983, 'GABA AGONIST TREATMENT IMPROVES TARDIVE DYSKINESIA', The Lancet, vol. 322, no. 8341, pp. 97-98. https://doi.org/10.1016/S0140-6736(83)90075-2
Tamminga, C. A. ; Thaker, G. K. ; Ferraro, T. N. ; Hare, T. A. / GABA AGONIST TREATMENT IMPROVES TARDIVE DYSKINESIA. In: The Lancet. 1983 ; Vol. 322, No. 8341. pp. 97-98.
@article{cd76ed78d8dd4fa690d64a57f9e5685a,
title = "GABA AGONIST TREATMENT IMPROVES TARDIVE DYSKINESIA",
author = "Tamminga, {C. A.} and Thaker, {G. K.} and Ferraro, {T. N.} and Hare, {T. A.}",
year = "1983",
month = "7",
day = "9",
doi = "10.1016/S0140-6736(83)90075-2",
language = "English (US)",
volume = "322",
pages = "97--98",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8341",

}

TY - JOUR

T1 - GABA AGONIST TREATMENT IMPROVES TARDIVE DYSKINESIA

AU - Tamminga, C. A.

AU - Thaker, G. K.

AU - Ferraro, T. N.

AU - Hare, T. A.

PY - 1983/7/9

Y1 - 1983/7/9

UR - http://www.scopus.com/inward/record.url?scp=0020539295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020539295&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(83)90075-2

DO - 10.1016/S0140-6736(83)90075-2

M3 - Article

VL - 322

SP - 97

EP - 98

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8341

ER -